Information about Gans Investors
My details
*
*
*
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Gans Investors (SPRL)

BE 0865.470.523

Mollenveldwijk 22A, 3271 Scherpenheuvel-Zichem
Company information
Status
Active
Enterprise number
BE0865.470.523
VAT liability
Yes
Established
13-05-2004
Last balance sheet year
2023
Company size
Medium-sized 0 FTE
Commercial name
Apotheek Rooseleers
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Gans Investors
{{translate("download")}}

Publications in the Belgian Official Journal from Gans Investors

Date Publication
27-07-2023 Capital - Shares - Resignations - Appointments (NL)
08-01-2018 Designation - Registered Office - Goal - Capital - Shares (NL)
21-03-2014 Capital - Shares - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
08-06-2004 Constitution (NL)

Frequently asked questions

What is the VAT number of Gans Investors?
The VAT number of Gans Investors is BE0865470523.
When was Gans Investors founded?
Gans Investors was founded on 13-05-2004.
What is the address of Gans Investors?
The current registered office of Gans Investors is located at Mollenveldwijk 22A, 3271 Scherpenheuvel-Zichem.
When was the last time Gans Investors filed their annual financial statements?
The most recent financial statements of Gans Investors were filed on 17-09-2024. You can view them here.
How many employees does Gans Investors have?
There are currently no employees working at Gans Investors or no workforce information is available.
What is the annual turnover of Gans Investors?
At the time of its most recent financial statements, Gans Investors did not publish any turnover figures. Gans Investors reported a gross margin of €75,852.13.

Sources